ORIP OneTouch
ORIP OneTouch is not just another medical device; it is a platform technology that has wide range of potential applications based on proven effects of remote ischemic pre-conditioning...                       read more

  CONSULTING
Our business is helping companies succeed in mending broken hearts. Regenerative Cardiology is all that we do for our clients, and do it as no one else does.      read more

PRODUCTS
We have acquired a novel platform of intellectual properties that enable growth and improvement of cardiac tissue non-invasively and boost the efficacy of current protein, gene or stem cell therapy approaches. Based on our proprietary platform technology new products are schedule to be announced in 2010.

COROPRATE PARTNERSHIPS
Inquiries for corporate partnerships from companies conducting clinical developments in regenerative cardiology are welcome.

INVESTORS
Neocardium is currently seeking participation from investors / equity partners to raise the seed capital for product development and strategic alliances for clinical trials.s.